AUA: Clinically Localized Prostate Cancer (2017): Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 March 2022

10 December 2021

  • curprev 16:5316:53, 10 December 2021‎ 24.61.20.101 talk‎ 30,783 bytes −70‎ No edit summary undo
  • curprev 16:4916:49, 10 December 2021‎ Urology4all talk contribs‎ 30,853 bytes +30,853‎ Created page with " ==== AUA GUIDELINE: CLINICALLY LOCALIZED PROSTATE CANCER 2017 ==== ===== Risk stratification ===== * '''Very low risk''' *# '''PSA <10 ng/ml AND''' *# '''Grade Group 1 AND''' *# '''Clinical stage T1-T2a AND''' *# '''<34% of biopsy cores positive AND''' *# '''No core with >50% involved AND''' *# '''PSA density <0.15 ng/ml/cc''' * '''Low risk''' *# '''PSA <10 ng/ml AND''' *# '''Grade Group 1 AND''' *# '''Clinical stage T1-T2a''' * '''Intermediate risk''' ** '''PSA 10-<2..." Tag: Visual edit
Retrieved from "https://urologyschool.com/wikiuro/index.php/AUA:_Clinically_Localized_Prostate_Cancer_(2017)"